While no mechanistic trials have specifically examined GLP‐1 RAs in HF, emerging data suggest potential benefits beyond weight reduction, possibly mediated by the widespread distribution of GLP‐1 receptors across multiple organ systems.9 The gene discussed is GLP1R; the disease is hydrops fetalis.